Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
Pharma
Idorsia's Tryvio nabs FDA approval following buyback from J&J
Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, the company said.
Zoey Becker
Mar 20, 2024 12:40pm
Novartis pays $245M to settle Exforge generic pay-for-delay suit
Jan 3, 2023 11:22am
Alcon is adding 2 more arrows to its opthalmic eye drop quiver
Aug 23, 2022 9:24am
Sanofi pulls hypertension meds in Korea, Canada and the U.K.
Aug 10, 2021 9:14am
Alnylam takes biannual hypertension prospect into phase 2 trial
Jul 6, 2021 7:40am
Labeling error prompts recall of Alembic hypertension med
Mar 25, 2021 8:16am